Results 291 to 300 of about 304,324 (330)
CAR‐T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy?
Allergy, EarlyView.
Federico Rossi+2 more
wiley +1 more source
Systemic Lupus Erythematosus-Associated Thrombotic Thrombocytopenic Purpura: A Case Report. [PDF]
Es-Saad O+4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2016
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many organs, including the skin, joints, the central nervous system and the kidneys. Women of childbearing age and certain racial groups are typically predisposed to developing the condition. Rare, inherited, single-gene complement deficiencies are strongly associated with SLE,
Kaul, Arvind+7 more
semanticscholar +11 more sources
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many organs, including the skin, joints, the central nervous system and the kidneys. Women of childbearing age and certain racial groups are typically predisposed to developing the condition. Rare, inherited, single-gene complement deficiencies are strongly associated with SLE,
Kaul, Arvind+7 more
semanticscholar +11 more sources
Arthritis & Rheumatism, 1997
In 1982, the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology (ACR)published revised criteria for the classification of systemiclupus erythematosus (SLE) (1). During the ensuing decade several investigators, including
Mph Marc C. Hochberg
semanticscholar +1 more source
In 1982, the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology (ACR)published revised criteria for the classification of systemiclupus erythematosus (SLE) (1). During the ensuing decade several investigators, including
Mph Marc C. Hochberg
semanticscholar +1 more source
The 1982 revised criteria for the classification of systemic lupus erythematosus.
Arthritis & Rheumatism, 1982The 1971 preliminary criteria for the classification of systemic lupus erythematosus (SLE) were revised and updated to incorporate new immunologic knowledge and improve disease classification.
E. M. Tan+8 more
semanticscholar +1 more source
Archives of Neurology, 1989
Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. To facilitate research in this area, we developed a fatigue severity scale, subjected it to tests of internal consistency and validity, and used it to compare ...
L. Krupp+3 more
semanticscholar +1 more source
Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. To facilitate research in this area, we developed a fatigue severity scale, subjected it to tests of internal consistency and validity, and used it to compare ...
L. Krupp+3 more
semanticscholar +1 more source
Pediatric Clinics of North America, 2005
Systemic lupus erythematosus (SLE) in children and adolescents is a multisystem autoimmune disease with a great variability in disease presentation and course. The diagnosis of SLE is based on the clinical and laboratory features consistent with this illness in the absence of other autoimmune disease that could explain the findings.
Earl D. Silverman, Susanne M. Benseler
openaire +4 more sources
Systemic lupus erythematosus (SLE) in children and adolescents is a multisystem autoimmune disease with a great variability in disease presentation and course. The diagnosis of SLE is based on the clinical and laboratory features consistent with this illness in the absence of other autoimmune disease that could explain the findings.
Earl D. Silverman, Susanne M. Benseler
openaire +4 more sources
New England Journal of Medicine, 2008
In their review article, Rahman and Isenberg (Feb. 28 issue)1 emphasize the role of anti–double-stranded DNA antibodies in the pathogenesis of systemic lupus erythematosus. Such antibodies also occur, however, in 23 to 64% of patients with type 1 autoimmune hepatitis, depending on the assay used.2 Interestingly, 36% of patients with type 1 autoimmune ...
Cynthia Aranow+2 more
openaire +4 more sources
In their review article, Rahman and Isenberg (Feb. 28 issue)1 emphasize the role of anti–double-stranded DNA antibodies in the pathogenesis of systemic lupus erythematosus. Such antibodies also occur, however, in 23 to 64% of patients with type 1 autoimmune hepatitis, depending on the assay used.2 Interestingly, 36% of patients with type 1 autoimmune ...
Cynthia Aranow+2 more
openaire +4 more sources